Triosephosphate isomerase
Triosephosphate isomerase 1 (23-37) is a synthetic peptide fragment corresponding to amino acid residues 23 through 37 of the human triosephosphate isomerase (TPI1) enzyme. As a segment derived from a highly conserved glycolytic enzyme, this peptide represents a valuable tool for investigating protein structure-function relationships, enzyme regulation, and cellular metabolic pathways. Its sequence encompasses a region implicated in substrate binding and conformational stability, making it especially relevant for studies focused on enzymatic dynamics and protein-protein interactions. The use of such defined peptide fragments enables researchers to dissect the molecular underpinnings of TPI1's activity, interactions, and regulation in health and disease models.
Enzyme mechanism studies: The 23-37 peptide fragment of TPI1 is frequently utilized in biochemical assays designed to probe the mechanistic aspects of triosephosphate isomerase catalysis. By isolating this specific region, researchers can analyze the contribution of key residues to substrate recognition, transition state stabilization, and catalytic efficiency. Such studies are instrumental in elucidating the detailed molecular events underlying isomerization reactions within the glycolytic pathway, providing insights that are difficult to obtain from full-length protein analysis alone.
Protein-protein interaction mapping: The defined sequence of this TPI1-derived peptide allows for precise mapping of interaction sites with other glycolytic enzymes, regulatory proteins, or potential binding partners. By employing the peptide in pulldown assays, cross-linking experiments, or surface plasmon resonance studies, investigators can identify and characterize direct contacts and binding affinities. These approaches are particularly valuable for constructing interaction networks and understanding how metabolic flux is coordinated through multi-enzyme complexes.
Epitope characterization and antibody development: The 23-37 region of TPI1 serves as a well-defined linear epitope for generating and validating antibodies specific to this segment of the enzyme. Synthetic peptides such as this are commonly used for immunization, affinity purification, or epitope mapping, enabling the production of reagents with high specificity. Such antibodies are crucial for applications including Western blotting, immunoprecipitation, and immunofluorescence, where precise detection of TPI1 or its fragments is required.
Structural biology and conformational analysis: Incorporation of the TPI1 (23-37) peptide in structural studies, such as nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography, facilitates the investigation of local secondary structure, flexibility, and folding propensity. By examining this fragment in isolation or in complex with ligands, researchers can gain detailed information about the conformational preferences of functionally important regions. These insights contribute to a deeper understanding of how local structure influences overall enzyme stability and function.
Peptide-based inhibitor screening: Synthetic peptides derived from enzymatic active sites or substrate-binding regions are often employed in the screening and design of small molecule inhibitors. The TPI1 (23-37) fragment can serve as a competitive template in binding assays aimed at identifying molecules that disrupt critical interactions within the enzyme. Such studies support the rational development of metabolic modulators and provide a foundation for exploring new strategies in the regulation of glycolytic flux at the molecular level.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More